Céline Callens Selected Research

Céline Callens Research Topics

Disease

19	Neoplasms (Cancer) 04/2024 - 01/2012
16	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2012
3	Disease Progression 02/2024 - 11/2022
3	Lung Neoplasms (Lung Cancer) 02/2023 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 11/2019
2	Carcinogenesis 10/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2015
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2020
2	Triple Negative Breast Neoplasms 01/2018 - 01/2012
2	Celiac Disease (Celiac Sprue) 05/2013 - 12/2012
1	Neutropenia 11/2022
1	Lymphopenia (Lymphocytopenia) 11/2022
1	Fatigue 11/2022
1	Adenocarcinoma 12/2020
1	Oncogene Addiction 12/2020
1	Meningeal Carcinomatosis 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Residual Neoplasm 07/2014
1	Leukemia 11/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2013
1	Inflammatory Breast Neoplasms 08/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2012
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Tauopathies 01/2012
1	Ataxia (Dyssynergia) 01/2012
1	Pathologic Processes 01/2012
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2011
1	Infections 11/2009

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 04/2015
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2009
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2012
3	pembrolizumabIBA 02/2024 - 12/2020
3	Immune Checkpoint InhibitorsIBA 02/2024 - 12/2020
3	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2016
2	Fulvestrant (Faslodex)FDA Link 02/2024 - 11/2022
2	Everolimus FDA Link 02/2024 - 01/2016
2	IronIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2018
2	Chelating AgentsIBA 01/2020 - 01/2018
2	osimertinibIBA 11/2019 - 01/2017
2	Deferasirox FDA Link 01/2018 - 01/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2015
1	Cell-Free Nucleic AcidsIBA 02/2024
1	patritumab deruxtecanIBA 02/2023
1	amivantamab-vmjwIBA 02/2023
1	ElementsIBA 01/2023
1	B7-H1 AntigenIBA 12/2022
1	exemestane (Aromasin)FDA Link 11/2022
1	Aromatase InhibitorsIBA 11/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2022
1	palbociclibIBA 11/2022
1	Letrozole (Femara)FDA LinkGeneric 11/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	rucaparibIBA 12/2021
1	ClaudinsIBA 10/2021
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	olaparibIBA 01/2021
1	ParaffinIBA 01/2021
1	PlatinumIBA 01/2021
1	taxaneIBA 01/2021
1	NivolumabIBA 12/2020
1	Forkhead Box Protein O3IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Forkhead Box Protein O1IBA 01/2020
1	Hormones (Hormone)IBA 10/2018
1	abirateroneIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2016
1	Celecoxib (Celebrex)FDA Link 12/2016
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Circulating Tumor DNAIBA 04/2015
1	purineIBA 07/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2013
1	Anaplastic Lymphoma KinaseIBA 08/2013
1	Serum AlbuminIBA 05/2013
1	Vitamin D FDA LinkGeneric 01/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Estrogens (Estrogen)FDA Link 01/2012
1	Hepatocyte Nuclear Factor 6IBA 06/2011
1	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 06/2011
1	LipidsIBA 11/2009

Therapy/Procedure

14	Therapeutics 02/2023 - 10/2012
7	Drug Therapy (Chemotherapy) 12/2022 - 05/2013
2	Precision Medicine 04/2016 - 04/2015
1	Immunotherapy 12/2020
1	Gluten-Free Diet 12/2012